In order to promote academic exchanges and experience sharing of standardized diagnosis and treatment of esophageal cancer, promote the standardization and standardization of diagnosis and treatment of esophageal cancer in my country, and gradually realize standardization, specialization, standardization, refinement and informationization, and ultimately benefit the majority of patients. On March 5, 2022, the first session of the esophageal cancer standardized diagnosis and treatment exchange-youth college project sponsored by the Chengdu High-tech Medical Association was successfully held in Chongqing. Exchange and interactive discussions to improve the diagnosis and treatment level of young doctors and continue to learn.

The meeting was opened and summarized by Prof. Han Yongtao from Sichuan Cancer Hospital and Prof. Wang Tianhu from the Third Affiliated Hospital of Chongqing Medical University. Professor Leng Xuefeng from Sichuan Cancer Hospital focused on the interpretation of "Progress in Perioperative Immunotherapy for Esophageal Cancer"; Professor Shi Qiuling from Chongqing Medical University focused on sharing "Methodological Considerations for the Application of Patient-Reported Outcomes in Extrathoracic Clinical Research" ;Professor Wang Peiyuan from Fujian Cancer Hospital and Professor Liu Jie from the First Affiliated Hospital of Army Medical University shared and explained the esophageal cancer immune case; according to the teaching content of the participating experts, all the professors launched a stimulating discussion.

This conference provides a platform for clinical doctors and scientific researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to academic discussions and exchanges of classic cases and cutting-edge technologies in the promotion of tumor immunity, and establishes comprehensive and standardized treatment of oncology medicine. concept. It is of great significance to promote high-quality clinical research in the field of medical oncology and promote the level of clinical scientific research.